Dr Reddy’s Laboratories failed to cheer the market despite June quarter net profit doubling. Analysts see concern over the US business and pressure on operating performance as key drags. These concerns have prompted traders to build bearish bets on the stock. Chandan Taparia, derivative analyst at Motilal Oswal, said the weakness could continue and the stock could drift down to Rs 3,950.
Market Trading Guide: Maruti Suzuki, NMDC among top 6 stock recommendations for Monday
Indian equities tracking positive global cues ended higher on the last trading day of the week. Nifty at the close edged higher by 0.25% to